Kaiming Sun is an accomplished professional in the field of translational science and clinical biomarkers, currently serving as Executive Director of Clinical Biomarkers at Recursion since December 2025, while also holding consultancy roles at Myrobalan Therapeutics and TRIANA Biomedicines. Previously, Kaiming led pivotal translational strategies at organizations including Nested Therapeutics and Evive Biotech, driving significant advancements in precision oncology and translational research across various indications. Kaiming has extensive experience in managing biomarker development and clinical strategies, particularly noted during tenures at MorphoSys and GSK, contributing to the successful commercialization of therapeutic products. Kaiming holds a Ph.D. in Molecular and Cellular Biology from Brandeis University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices